2022 annual financial data
Monopar Therapeutics 2022 Operating margin
Monopar Therapeutics 2022 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -10,536,877 USD and net income was -10,494,399 USD.
Operating cash flow was -7,228,559 USD.
Get free Monopar Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -10,536,877 USD
- Net income
- -10,494,399 USD
- Operating cash flow
- -7,228,559 USD